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Relation Between Central Venous, Peripheral Venous
and Arterial Lactate Levels in Patients With Sepsis
in the Emergency Department
Dimitrios Velissarisa, b, Vasileios Karamouzosc, Nikolaos Dimitrios Pantzarisd,
Ourania Kyriakopouloub, Charalampos Gogosa,
Menelaos Karanikolase, f
Abstract
Background: Sepsis and multi-organ failure remain a major clinical
problem with high morbidity and mortality worldwide. Lactate measurement remains part of the initial assessment and management of
patients with sepsis. Although arterial blood is most commonly used
for lactate measurement, there is increasing use of peripheral venous
lactate for initial assessment and for monitoring of response to treatment in patients with sepsis. The aim of this study was to evaluate the
relation between lactate levels measured from central line, peripheral
vein and arterial line in patients treated for sepsis in the emergency
department (ED).
Methods: This prospective study enrolled 31 patients with diagnosis
of sepsis who were evaluated and treated in the ED of a university
hospital. During initial resuscitation, blood samples from the artery,
peripheral vein and central vein (when available) were collected and
lactate concentrations were measured. Correlation between lactate
values from the three different locations was assessed using Pearson
correlation. Bland-Altman plots were used to evaluate agreement between lactate measurements in different sampling locations. All patients were eventually admitted to the Internal Medicine Department
ward or to the intensive care unit (ICU) for further treatment.
Results: Our data showed strong, highly significant correlation between arterial and peripheral venous lactate levels (r = 0.880, P <
0.0001), between arterial and central venous blood lactate (r = 0.898,
P < 0.0001) and between central and peripheral venous blood lactate
(r = 0.941, P < 0.0001).
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Conclusions: In this study we observed strong correlation between
arterial, central vein and peripheral vein lactate concentrations in 31
patients assessed and treated for sepsis. We suggest that lactate measurement in peripheral venous blood could be used for screening and for
monitoring response to therapy in sepsis patients. However, because
this is a small study in only 31 patients and published data are limited,
larger studies are needed in order to confirm the validity of our findings.
Keywords: Sepsis; Arterial lactate; Peripheral venous lactate; Central
venous lactate; Monitoring; Resuscitation

Introduction
Sepsis and the resulting multi-organ failure are still associated
with high morbidity and mortality rates [1]. The management
of patients with sepsis should begin in the emergency department (ED) in accordance with the international guidelines of
the Surviving Sepsis Campaign [2]. Serial lactate concentration measurements are helpful in evaluating the progression of
sepsis and can guide decision-making by clinicians.
Most clinicians use arterial blood samples to measure lactate levels. However, in the ED setting and especially in conscious patients, arterial puncture causes patient discomfort and
also has a small risk of arterial injury or other complications,
including thrombosis and ischemia [3]. As an alternative to arterial sampling, clinicians sometimes use repeated lactate measurements via peripheral or central veins when available, and peripheral venous lactate sampling has been used as part of routine
blood testing in some cases [4, 5]. However, only a few studies
have evaluated the role of venous blood lactate measurements
as alternative to arterial blood sampling. The aim of this study
is to evaluate the interchangeability of the arterial blood lactate
with the peripheral venous lactate and the central venous lactate
(CV-lactate) in patients with sepsis treated in the ED.

Materials and Methods
This prospective study was conducted in the Emergency
Department of the University Hospital of Patras, in Western
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Greece, between November 2017 and May 2018 and enrolled
31 patients. Inclusion criteria were age > 18 years and diagnosis of sepsis of any origin confirmed by clinical examination,
laboratory tests, radiographic findings (e.g. chest X-ray) or any
other intervention performed in the ED.
Exclusion criteria were known liver or renal failure, and
metformin use. The diagnosis of sepsis was established according to the recently published Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) definitions criteria [6]. All patients were assessed and treated in
the resuscitation room of the ED in accordance with the initial
resuscitation guidelines of the Surviving Sepsis Campaign [2].
A central line was inserted in patients with poor peripheral
access and in patients who required support with continuous
infusion of vasopressors for resuscitation purposes. Three separate blood samples were simultaneously obtained from central
and peripheral veins and arterial sampling for lactate analysis.
All blood samples were immediately analyzed in a point of care
blood gas analyzer (Stat Profile pHOx Ultra TM/CCXTMLactate
Membrane Kit, NOVA BIOMEDICAL, Waltham, MA, USA).
The study was conducted in compliance with the ethical
standards of the responsible institution on human subjects and
with the Helsinki Declaration. The study protocol was approved by the Institutional Review Board of the University
Hospital. All patients (or their legal guardian) gave written
informed consent before enrolling in the study. Data collected for the study were anonymized and stored in an encrypted
electronic database. The medical team involved in the study
included University of Patras faculty, resident physicians rotating through the ED and outside consultants.
Statistical analysis
All patient data were anonymized, entered in a secure electronic database and stored in a secure, encrypted personal
computer. Data were analyzed using the MedCalc Statistical
Software version 18.11.6 (MedCalc Software bvba, Ostend,
Belgium; https://www.medcalc.org; 2019). Normality of data
distribution was assessed using the Kolgomorov-Smirnov test.
Repeated measures analysis of variance (ANOVA) was used to
compare lactate levels in arterial blood versus peripheral vein
versus central vein samples, and paired t-test was used for post
hoc analysis when indicated.
Correlation between lactate values from the three different
locations was assessed using Pearson correlation. When correlations were significant, linear regression analysis was conducted in order to assess how well the values of one variable
(on the X axis) can predict the values of the other variable
(on the Y axis). Data are presented as mean ± standard deviation (SD) or as median (min, max) as appropriate. P < 0.05
was considered statistically significant for all analysis. BlandAltman plots were generated to evaluate agreement in lactate
measurements between the three different sampling locations.

Results
In total, 31 patients were included in the study. Data were col630
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lected from 31 patients, 13 men and 18 women. Patient age
was 75.1 ± 9.7 for men versus 79.1 ± 14 for women, and there
were no significant differences between men and women. Lactate levels were measured in arterial blood in 26 patients, in
central venous blood in 16 patients and in peripheral venous
blood in 29 patients. As a result, we could compare and correlate arterial versus peripheral vein samples in 26 patients, but
we had data from all three sources in only 13 patients.
Comparison between variables using repeated measures
ANOVA showed that there was no significant difference between lactate levels in arterial (3.08 ± 1.56) versus peripheral
venous (3.1 ± 1.78) versus central venous blood (3.22 ± 1.92,
P > 0.8, Fig. 1).
There was very strong, highly significant correlation between arterial and peripheral venous lactate levels (Pearson’s
r = 0.880, P < 0.0001), between arterial and central venous
blood (Pearson’s r = 0.898, P < 0.0001) and between central
and peripheral venous blood (Pearson’s r = 0.941, P < 0.0001).
Results of correlation analysis for lactate concentrations in different samples are summarized in Table 1.
Regression analysis showed that lactate concentration in
peripheral vein blood is a strong, highly significant but imperfect predictor of lactate concentration in arterial blood (r
= 0.88, P < 0.001, Fig. 2a) and in central venous blood (r =
0.94, P < 0.001, Fig. 2b). Regression analysis also showed that
lactate concentration in central vein blood is a strong, highly
significant but imperfect predictor of lactate concentration in
arterial blood (r = 0.90, P < 0.001, Fig. 2c).
Bland-Altman plot analysis showed good agreement between lactate concentration in central vein and that in peripheral vein (Fig. 3a), between lactate concentration in central vein
and that in arterial blood (Fig. 3b), and between lactate concentration in peripheral vein and that in arterial blood (Fig. 3c).

Discussion
The sepsis syndrome has complex underlying pathophysiology with severe cellular and metabolic abnormalities leading
to cellular metabolism imbalance resulting in increased lactate
production [7]. When tissue hypoxia exists, lactate is overproduced due to increased anaerobic glycolysis, while lactate
clearance occurs mostly in the liver (60%), followed by the
kidney (30%). The lactate clearance cannot overcome the increased lactate production during the critically ill status. Because liver dysfunction and kidney injury elevate lactate levels
due to decreased lactate clearance, we exclude patients with
these underlying conditions from our study.
Blood lactate levels can be used as marker for systemic
tissue hypoperfusion and disease severity in sepsis: in one
large retrospective study from the Netherlands, a 24-h mean
lactate > 2 mmol/L was a strong predictor of intensive care unit
(ICU) mortality [8], and the range of lactate values reported in
this study were quite similar to the lactate values reported in
our study.
Serum lactate concentration is included in the criteria for
septic shock defined in Sepsis-3 [6]. Lactate level > 2 mmol/L
(18 mg/dL) after adequate fluid resuscitation and the need for
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Figure 1. Box-plot diagrams comparing arterial versus central vein versus peripheral vein lactate levels. There are no significant
differences between the three sample sites.

vasopressor therapy in order to maintain mean arterial pressure
> 65 mm Hg characterize septic shock [6, 9]. Most published
research has focused on lactate level measurements using arterial blood sampling in ED patients with sepsis. However, in the
newer definition of septic shock, venous blood lactate levels
seem to accurately reflect the abnormal cell-based metabolism
and lactate levels can be considered as emerging vital signs
[10].
In this prospective observational single center study, we
saw a strong, clinically relevant and statistically highly significant correlation between lactate levels measured in the peripheral artery, central and peripheral veins during initial resuscitation in patients with sepsis. These results are in agreement with

the findings of a prospective observational study published by
Datta et al in 2018, which demonstrated good agreement between arterial lactate and peripheral lactate levels when lactate levels were > 2 mmol/L in 304 patients with sepsis [11].
Strengths of our study include prospective study design and
biologically plausible, highly significant, clinically relevant
results. Limitations of our study include the small sample size
and the fact that we did not categorize patients based on a specific threshold for lactate concentrations.
Early goal-directed resuscitation protocols used for treatment of patients with sepsis and septic shock aim at reducing mortality [12]. Clinicians often use serial blood lactate
level measurements in order to assess disease progression,

Table 1. Correlations Between Arterial, Peripheral Vein and Ventral Vein Lactate Values
Sites of lactate measurement

Arterial

Peripheral vein

Central vein

   Pearson correlation coefficient

0.880

0.898

   Significance level P

< 0.0001

< 0.0001

  n

26

13

Arterial

Peripheral vein
   Pearson correlation coefficient

0.880

0.941

   Significance level P

< 0.0001

< 0.0001

  n

26

16

Central vein
   Pearson correlation coefficient

0.898

0.941

   Significance level P

< 0.0001

< 0.0001

  n

13

16
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Figure 2. Linear regression analysis: peripheral blood lactate is a strong, highly significant but imperfect predictor of arterial blood
lactate (r = 0.88, P < 0.001) (a), peripheral vein lactate is a strong, highly significant but imperfect predictor of central vein lactate
(r = 0.94, P < 0.001) (b), and central vein lactate is a strong, highly significant but imperfect predictor of arterial blood lactate (r
= 0.90, P < 0.001) (c).
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Figure 3. Bland-Altman plot shows good agreement between central vein lactate and peripheral vein lactate (a), between central
vein lactate and arterial blood lactate (b) and between arterial blood lactate and peripheral vein lactate (c).

and arterial puncture samples are most commonly used for
lactate level measurement in the blood gas analyzer. However,
repeated arterial punctures cause patient discomfort or pain

and are associated with small risk of complications, including
damage of the artery, bleeding and arterial thrombosis with
hand ischemia. Peripheral venous and central venous blood
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samples can easily be obtained by healthcare professionals
with various degrees of skill and experience, have lower risk
of complications and sampling is less painful for patients. In
cases where placement of a central line is necessary, there are
more risks during central line insertion, but fewer disadvantages afterwards.
Based on earlier publications that have demonstrated
strong but imperfect agreement between arterial and venous
lactate levels [6], use of peripheral vein lactate has been recommended for screening in patients with sepsis [11]. However,
we did not identify any publications evaluating the agreement
between arterial, venous and central venous lactate levels in
patients with sepsis.
In conclusion, based on the strong agreement between venous, arterial and central venous lactate values in our data, it
may be reasonable to use peripheral venous or central venous
blood samples for measuring lactate levels in order to monitor
disease progression and response to therapy in patients with
sepsis. However, because this is a small, single center study,
additional larger studies are needed to confirm or disprove the
validity of our findings.
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